Impact of anti-citrullinated protein antibody on tumor necrosis factor inhibitor or abatacept response in patients with rheumatoid arthritis

• Kathleen Tymms,
• Belinda Butcher,
• Tegan Smith,
• Geoffrey Littlejohn,
• OPAL Consortium

Affiliations

Kathleen Tymms

Canberra Rheumatology, Canberra City, Australian Capital Territory, Australia;OPAL Rheumatology Ltd, Sydney, New South Wales, Australia

Belinda Butcher

WriteSource Medical Pty Ltd, Lane Cove, New South Wales, Australia;School of Medical Sciences, University of New South Wales, Kensington, New South Wales, Australia

Tegan Smith

OPAL Rheumatology Ltd, Sydney, New South Wales, Australia

Geoffrey Littlejohn

OPAL Rheumatology Ltd, Sydney, New South Wales, Australia;Monash Rheumatology, Clayton, Victoria, Australia

OPAL Consortium

OPAL Consortium